In this article, we are going to talk about Q2 Results Today. Adani Ports & SEZ, Zee Entertainment Enterprises, Ashok Leyland, Muthoot Finance, BEML, and many other companies’ shares are going to be the focus today as these firms will declare their income for the second quarter of FY24. Since the news came on the internet it has gone viral on many social media platforms. Now thousands of people are super keen to know about the Q2 Results Today. Here we have more information about it and we will share it with you in this article, so let’s continue the article.
Q2 earnings results today
According to the available data, a total of 719 firms are going to release Q2 results today. The companies that will announce their Q2 results today include Aurobindo Pharma, Page Industries, ABB, Piramal Enterprises, Cholamandalam Financial Holdings, GlaxoSmithKline Pharma, SJVN, Abbott India, Bosch, Dish TV India, Torrent Power, NBCC India, Finolex Cables, The Ramco Cements, eClerx Service, NCC, NALCO, Suven Pharma, Graphite India, Granules India, among others. Additionally, Bajaj Hindusthan Sugar, Engineers India, Bajaj Consumer Care, Campus Activewear, Force Motors, Hinduja Global, IRCON International, and Kirloskar Industries, among others will also report their Q2 earning today. Scroll down to the next page for more information about the news.
Ashok Leyland
Ashok Leyland is an Indian multinational automotive manufacturer, with their headquarters in Chennai. It is owned by the Hinduja Group. Its net earnings in Q2FY24 are predicted to jump 214% to ₹599.7 crores from ₹191.1 crores in the same quarter the previous year. The firm’s revenue to increase 19% to ₹9,808.7 crore from ₹8,266 crore, YoY. Revenue development YoY is possible to be driven by growth in volumes, better mix, and price growth. You are on the right page for more information about the news so please read the complete article.
Aurobindo Pharma
Aurobindo Pharma Limited is an Indian multinational drug manufacturing firm headquartered in HITEC City, Hyderabad, India. Drug major Aurobindo Pharma is anticipated to report a net profit of ₹680.4 crore in the quarter finished September this year, registering a development of 66% from ₹409.4 crore, YoY. Payment has been predicted to increase 21% YoY to ₹6,961.4 crore, while EBITDA is evaluated to rise 44% YoY to ₹1,207.3 crore.US sales have been expected to enhance 1% QoQ to $405 million despite the shutdown of the Puerto Rico plant. Here we have shared all the information that we had if we get any information then we will update you soon. Stay tuned to us for more updates.